The Risk Ratio of Immune-Related Colitis, Hepatitis, and Pancreatitis in Patients With Solid Tumors Caused by PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00261
Full Text
Open PDFAbstract
Available in full text
Date
February 28, 2020
Authors
Publisher
Frontiers Media SA